| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |